Trend of Survival of a Cohort of Chinese Patients With Systemic Lupus Erythematosus Over 25 Years
- PMID: 33015102
- PMCID: PMC7516076
- DOI: 10.3389/fmed.2020.00552
Trend of Survival of a Cohort of Chinese Patients With Systemic Lupus Erythematosus Over 25 Years
Abstract
Objectives: To revisit the trend of survival of systemic lupus erythematosus in a cohort of Chinese patients over 25 years. Methods: Patients who fulfilled the 1997 ACR criteria for SLE and were followed in our hospital since 1995 were included. Patients were stratified into two groups according to the year of diagnosis: (1) 1995-2004 and (2) 2005-2018. Survival of patients was studied by Kaplan-Meier analysis. Organ damage as assessed by the Systemic Lupus International Collaborating Clinics (SLICC) damage index (SDI) and causes of death in the first 10 years of SLE onset was compared between the two groups. Cox regression was used to study factors associated with survival. Results: A total of 1,098 SLE patients were registered in our database. After excluding 157 patients diagnosed outside the time period of 1995-2018, 941 patients were studied (92% women). All were ethnic Chinese. The mean age of SLE onset was 35.1 ± 14.4 years, and the mean duration of observation was 13.1 ± 6.6 years. Seventy-seven (8.2%) patients were lost to follow-up. Groups 1 and 2 consisted of 364 and 577 patients, respectively. The mean SDI score at 10 years of disease onset was significantly higher in group 1 than group 2 patients (1.01 ± 1.43 vs. 0.57 ± 0.94; p < 0.01), particularly in the neuropsychiatric, musculoskeletal, and gonadal domains. Within 10 years of SLE onset, 32 (8.8%) patients in group 1 and 25 (4.3%) patients in group 2 died (p = 0.005). The 5- and 10-year cumulative survival rates were 93.6 and 91.0% in group 1 and 96.5 and 94.2% in group 2 patients, respectively (log-rank test p = 0.048). Infection accounted for more than half of the deaths in both groups. More group 1 than group 2 patients died of vascular events, but the difference was not statistically significant. Cox regression showed that the age of SLE onset and damage score accrued at 10 years, but not the time period in which SLE was diagnosed, were significantly associated with mortality. Conclusions: The improvement in survival of our SLE patients is probably related to the accrual of less organ damage in the past 15 years.
Keywords: damage; lupus; morbidity; mortality; time trend.
Copyright © 2020 Mok, Ho, Chan, Tse and To.
Figures
Similar articles
-
Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.Lupus. 2019 Apr;28(5):635-641. doi: 10.1177/0961203319839845. Epub 2019 Apr 2. Lupus. 2019. PMID: 30939980
-
High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.J Rheumatol. 2002 Jul;29(7):1398-400. J Rheumatol. 2002. PMID: 12136895
-
Mortality and disease related comorbidities in systemic lupus erythematosus: Data from an Egyptian cohort.Lupus. 2022 Apr;31(5):628-636. doi: 10.1177/09612033221081691. Epub 2022 Mar 20. Lupus. 2022. PMID: 35306918
-
Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort.Lupus. 2022 Feb;31(2):246-255. doi: 10.1177/09612033211069765. Epub 2022 Jan 16. Lupus. 2022. PMID: 35037500 Review.
-
Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.Rheumatology (Oxford). 2007 Aug;46(8):1290-6. doi: 10.1093/rheumatology/kem102. Epub 2007 May 23. Rheumatology (Oxford). 2007. PMID: 17522097 Review.
Cited by
-
Clinical Features and Survival Analysis of Lupus Nephritis among Patients with Systemic Lupus Erythematosus: A Three-Decade-Long Retrospective Cohort Study.Biomedicines. 2024 Sep 18;12(9):2117. doi: 10.3390/biomedicines12092117. Biomedicines. 2024. PMID: 39335630 Free PMC article.
-
10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry.Rheumatology (Oxford). 2023 Nov 2;62(11):3555-3564. doi: 10.1093/rheumatology/kead103. Rheumatology (Oxford). 2023. PMID: 36912696 Free PMC article.
-
Immunotargets and Therapy for Systemic Lupus Erythematosus.Immunotargets Ther. 2025 Jun 24;14:605-629. doi: 10.2147/ITT.S485650. eCollection 2025. Immunotargets Ther. 2025. PMID: 40585390 Free PMC article. Review.
-
High-density lipoprotein cholesterol subfraction HDL2 is associated with improved endothelial function in systemic lupus erythematosus.Lupus Sci Med. 2024 Jan 22;11(1):e001030. doi: 10.1136/lupus-2023-001030. Lupus Sci Med. 2024. PMID: 38262630 Free PMC article.
-
Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022.Rheumatology (Oxford). 2024 Aug 1;63(8):2109-2117. doi: 10.1093/rheumatology/kead519. Rheumatology (Oxford). 2024. PMID: 37769251 Free PMC article.
References
-
- Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, et al. . Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis. (2015) 74:1706–13. 10.1136/annrheumdis-2013-205171 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous